The Poop Project That Might Just Rescue Endangered Species
Jill Lopez Jill Lopez

The Poop Project That Might Just Rescue Endangered Species

At first glance, it might sound like a bizarre side quest from a science fiction novel — collecting animal feces to preserve life on Earth. But for Professor Suzannah Williams and her team at Oxford University, poop is a powerful tool in the fight to save wildlife.

Read More
Iowa State's $2 Million Boost: Paving the Way for the Future of Animal Disease Prevention
Jill Lopez Jill Lopez

Iowa State's $2 Million Boost: Paving the Way for the Future of Animal Disease Prevention

Iowa State University (ISU) has been awarded a significant $2 million grant from the U.S. Department of Agriculture (USDA) to launch a series of groundbreaking research projects focused on animal disease preparedness. This funding is part of the USDA’s broader National Animal Disease Preparedness and Response Program, which aims to bolster the detection, prevention, and response efforts to the most destructive diseases threatening U.S. livestock.

Read More
Akron Zoo's Groundbreaking New $12 Million Animal Hospital: A Game-Changer for Animal Care and Zoo Growth
Jill Lopez Jill Lopez

Akron Zoo's Groundbreaking New $12 Million Animal Hospital: A Game-Changer for Animal Care and Zoo Growth

The Akron Zoo is setting a new standard in animal care with the groundbreaking of a state-of-the-art animal hospitalthat will revolutionize how it provides medical care for its nearly 2,000 animals. This exciting development, which took place on April 11, 2025, marks a significant milestone in the zoo’s growth and its ongoing efforts to ensure the health and well-being of its animal residents.

Read More
FDA New Strategy To Replace Animal Testing: The Future of Drug Development is Human-Centered and Tech-Driven
Jill Lopez Jill Lopez

FDA New Strategy To Replace Animal Testing: The Future of Drug Development is Human-Centered and Tech-Driven

In a groundbreaking move towards more ethical and efficient drug development, the U.S. Food and Drug Administration (FDA) has announced a significant shift away from animal testing in the creation of monoclonal antibody therapies and other medications. This bold strategy promises to revolutionize how drugs are developed, evaluated, and brought to market, marking a new era where human-relevant methods take the lead.

Read More